Jacobi Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Buy
4,520
+472
+12% +$191K 0.12% 167
2025
Q1
$2.01M Sell
4,048
-32
-0.8% -$15.9K 0.15% 143
2024
Q4
$2.12M Buy
4,080
+57
+1% +$29.7K 0.16% 133
2024
Q3
$2.49M Buy
4,023
+85
+2% +$52.6K 0.19% 109
2024
Q2
$2.18M Buy
3,938
+13
+0.3% +$7.19K 0.19% 103
2024
Q1
$2.28M Buy
3,925
+74
+2% +$43K 0.21% 90
2023
Q4
$2.04M Sell
3,851
-11
-0.3% -$5.84K 0.21% 95
2023
Q3
$1.95M Buy
3,862
+178
+5% +$90.1K 0.22% 91
2023
Q2
$1.92M Sell
3,684
-364
-9% -$190K 0.22% 98
2023
Q1
$2.33M Buy
4,048
+103
+3% +$59.4K 0.28% 75
2022
Q4
$2.17M Buy
3,945
+119
+3% +$65.5K 0.27% 78
2022
Q3
$1.94M Buy
3,826
+16
+0.4% +$8.11K 0.27% 79
2022
Q2
$2.07M Buy
3,810
+21
+0.6% +$11.4K 0.28% 73
2022
Q1
$2.24M Buy
3,789
+174
+5% +$103K 0.27% 71
2021
Q4
$2.41M Buy
3,615
+166
+5% +$111K 0.29% 66
2021
Q3
$1.97M Buy
3,449
+33
+1% +$18.8K 0.25% 75
2021
Q2
$1.72M Buy
3,416
+303
+10% +$153K 0.23% 83
2021
Q1
$1.42M Buy
3,113
+209
+7% +$95.4K 0.21% 94
2020
Q4
$1.38M Buy
2,904
+18
+0.6% +$8.53K 0.22% 90
2020
Q3
$1.29M Buy
2,886
+438
+18% +$196K 0.23% 84
2020
Q2
$887K Buy
2,448
+11
+0.5% +$3.99K 0.17% 108
2020
Q1
$691K Sell
2,437
-442
-15% -$125K 0.15% 117
2019
Q4
$935K Buy
2,879
+45
+2% +$14.6K 0.17% 114
2019
Q3
$826K Buy
2,834
+19
+0.7% +$5.54K 0.16% 117
2019
Q2
$827K Buy
2,815
+199
+8% +$58.5K 0.17% 118
2019
Q1
$716K Buy
2,616
+16
+0.6% +$4.38K 0.18% 83
2018
Q4
$582K Buy
2,600
+1,540
+145% +$345K 0.16% 100
2018
Q3
$259K Hold
1,060
0.07% 175
2018
Q2
$219K Buy
1,060
+152
+17% +$31.4K 0.06% 192
2018
Q1
$184K Buy
908
+284
+46% +$57.6K 0.06% 195
2017
Q4
$126K Buy
624
+187
+43% +$37.8K 0.04% 226
2017
Q3
$84K Buy
437
+1
+0.2% +$192 0.03% 266
2017
Q2
$78K Hold
436
0.03% 247
2017
Q1
$67K Buy
436
+124
+40% +$19.1K 0.03% 205
2016
Q4
$46K Sell
312
-124
-28% -$18.3K 0.03% 224
2016
Q3
$69K Hold
436
0.03% 197
2016
Q2
$65K Buy
+436
New +$65K 0.03% 200